by Jordana Choucair | Oct 28, 2021 | Opioid/Substance Use Disorders
HHS Secretary Xavier Becerra announced a new federal overdose prevention strategy that prioritizes primary prevention, harm reduction, evidence-based treatment, and recovery support. The strategy supports the department’s commitment to helping historically underserved...
by Jordana Choucair | Oct 21, 2021 | Opioid/Substance Use Disorders
Recent CDC data demonstrates that the nation’s substance use disorder (SUD) epidemic has continued unabated since the onset of the COVID-19 pandemic. With indicators pointing in the wrong direction – and the pandemic still actively impacting individual and community...
by Jordana Choucair | Oct 14, 2021 | Opioid/Substance Use Disorders
On October 18, U.S. Congressman Dean Phillips (D-MN) and recovery advocates from Minnesota and across the nation will participate in a virtual recovery advocacy roundtable hosted by the Hazelden Betty Ford Foundation and Minnesota Recovery Connection. Participants...
by Jordana Choucair | Oct 7, 2021 | Opioid/Substance Use Disorders
Lobbyists are looking to block Senator Joe Manchin’s push to include a tax on prescription opioids to pay for addiction treatment as part of Democrats’ social spending package. Manchin has said adding the painkiller tax is a requirement for him to support...
by Jordana Choucair | Oct 5, 2021 | Opioid/Substance Use Disorders
David Smith and Greg Williams of Third Horizon Strategies participated in a Duke-Margolis Center for Health Policy roundtable focused on advancing payment and delivery reforms that can support expanded access to high-quality SUD treatment and recovery services. The...
by Jordana Choucair | Oct 1, 2021 | Opioid/Substance Use Disorders
• Four large pharmacy chains are set to face their first trial over the deadly U.S. opioid epidemic. Lawyers for the Ohio counties of Lake and Trumbull and companies – Walgreens Boots Alliance Inc, CVS Health Corp, Walmart Inc, and Giant Eagle Inc – are set to deliver...
Recent Comments